The analysis examined GLP-1 drug use following 382,277 pregnancies in Denmark from the beginning of 2018 through June 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback